Ramucirumab Paclitaxel
MinorIn patients with solid tumours, taking Cyramza (ramucirumab) together with other medicines in its approved combinations did not meaningfully change how much of either medicine was in the body. This held for paclitaxel, docetaxel, irinotecan (including its active breakdown product, SN-38) and erlotinib. So ramucirumab did not noticeably change the level of paclitaxel, and paclitaxel did not noticeably change the level of ramucirumab.
Little or no effect is expected. You usually do not need to change anything, but still tell your doctor or pharmacist about every medicine you take.